Double‐blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major dipressive episode
The DOI matches its Crossref record.
Abstract
The novel antidepressant agent milnacipran is a dual and equipotent serotonin and noradrenaline reuptake inhibitor. The aim of this double‐blind study was to compare the efficacy and safety of milnacipran (50 mg twice daily) with that of imipramine (50 mg twice daily) in elderly patients with major depressive episode. A total of 219 patients were randomly assigned to 8 weeks of double‐blind treatment with either milnacipran or imipramine; 72 patients withdrew from the study. At the end of treatment no significant differences were found between milnacipran and imipramine in antidepressant efficacy. A significantly greater number of side‐effects, particularly anticholinergic effects, was observed in the imipramine group. Milnacipran may be preferable to imipramine in elderly depressed patients, as it provides the same antidepressant activity as imipramine with a lower incidence of side‐effects, and does not impair cognitive ability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 311
Antidepressants for depressed elderly
Mottram, P. G., Wilson, K., & Strobl, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003491.pub2 · Cited by 287
Kok, R. M., Nolen, W. A., & Heeren, T. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.036 · Cited by 167
Baune, B. T., Brignone, M., & Larsen, K. G. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx070 · Cited by 140
Krause, M., Gutsmiedl, K., Bighelli, I., Schneider-Thoma, J., Chaimani, A., & Leucht, S. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.130 · Cited by 65
“…T: 150–300 6 65 71 DSM-III-R major depression DB-RCT Study 032a Reboxetine: n = 24 Placebo: n = 26 R: 4–6 8 63 79,96 DSM-III-R Major Depressive Disorder not accompanied by psychotic features DB-RCT Tignol et al. (1998) Imipramine: n = 107 Milnacipran: n = 112 I: 75–100 M: 75–100 8 65 74,10…”
Metadata
- Authors
- Tignol, J., Pujol‐Domenech, J., Chartres, J. P., Léger, J. ‐., Plétan, Y., Tonelli, I., Tournoux, A., & Pezous, N.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 1998-02
- Volume
- 97
- Issue
- 2
- Pages
- 157-165
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W1998937220
- Cited by
- 52
- References
- 0
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Double‐blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major dipressive episode. https://app.cochat.ai/papers/10.1111/j.1600-0447.1998.tb09980.x
- The paper
- Tignol, J., Pujol‐Domenech, J., Chartres, J. P., Léger, J. ‐., Plétan, Y., Tonelli, I., Tournoux, A., & Pezous, N. (1998). Double‐blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major dipressive episode. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1998.tb09980.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.